Display Settings:

Format

Send to:

Choose Destination
    J Transl Med. 2009 Feb 20;7:15.

    Feasibility investigation of allogeneic endometrial regenerative cells.

    Source

    Medistem Inc, San Diego, USA. jzhonguro@gmail.com

    Abstract

    Endometrial Regenerative Cells (ERC) are a population of mesenchymal-like stem cells having pluripotent differentiation activity and ability to induce neoangiogenesis. In vitro and animal studies suggest ERC are immune privileged and in certain situations actively suppress ongoing immune responses. In this paper we describe the production of clinical grade ERC and initial safety experiences in 4 patients with multiple sclerosis treated intravenously and intrathecally. The case with the longest follow up, of more than one year, revealed no immunological reactions or treatment associated adverse effects. These preliminary data suggest feasibility of clinical ERC administration and support further studies with this novel stem cell type.

    PMID:
    19232091
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2649897
    Free PMC Article

      Supplemental Content

      Icon for BioMed Central Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk